Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
International Journal of Technology Assessment in Health Care
|
September 15, 2016
TREATMENT SWITCHING IN CANCER TRIALS: ISSUES AND PROPOSALS
Chris Henshall, Nicholas R Latimer, Lloyd Sansom, et al.
International Journal of Technology Assessment in Health Care
|
July 16, 2011
Interactions between health technology assessment, coverage, and regulatory processes: emerging issues, goals, and opportunities
Chris Henshall, Logan Mardhani-Bayne, Katrine B Frønsdal, et al.
Journal of Comparative Effectiveness Research
|
July 13, 2017
Indication-specific pricing of pharmaceuticals in the US healthcare system
Steven D Pearson, William B Dreitlein, Chris Henshall, et al.
Journal of Comparative Effectiveness Research
|
September 28, 2019
Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy Summit
Steven D Pearson, Celia Segel, Amanda Cole, et al.
Journal of Comparative Effectiveness Research
|
March 1, 2021
Cornerstones of 'fair' drug coverage: appropriate cost sharing and utilization management policies for pharmaceuticals
Steven D Pearson, Adrian Towse, Maria Lowe, et al.
Journal of Comparative Effectiveness Research
|
November 17, 2017
Gene therapy: evidence, value and affordability in the US health care system
Grace Hampson, Adrian Towse, Steven D Pearson, et al.
Journal of Comparative Effectiveness Research
|
November 15, 2018
A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions
Steven D Pearson, William B Dreitlein, Adrian Towse, et al.
Journal of Comparative Effectiveness Research
|
November 10, 2018
Real-world evidence for coverage decisions: opportunities and challenges
Grace Hampson, Adrian Towse, William B Dreitlein, et al.
Health Affairs Scholar
|
June 10, 2024
Towards a coordinated approach for managing accelerated patient access to potentially beneficial medicines: reporting the perspectives of a multi-stakeholder, international workshop
Marie Phillips, Patricia Synnott, Chris Henshall, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?
Chris Henshall, Lloyd Sansom, Hans-Georg Eichler, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
International Journal of Technology Assessment in Health Care
|
September 15, 2016
TREATMENT SWITCHING IN CANCER TRIALS: ISSUES AND PROPOSALS
Chris Henshall, Nicholas R Latimer, Lloyd Sansom, et al.
International Journal of Technology Assessment in Health Care
|
July 16, 2011
Interactions between health technology assessment, coverage, and regulatory processes: emerging issues, goals, and opportunities
Chris Henshall, Logan Mardhani-Bayne, Katrine B Frønsdal, et al.
Journal of Comparative Effectiveness Research
|
July 13, 2017
Indication-specific pricing of pharmaceuticals in the US healthcare system
Steven D Pearson, William B Dreitlein, Chris Henshall, et al.
Journal of Comparative Effectiveness Research
|
September 28, 2019
Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy Summit
Steven D Pearson, Celia Segel, Amanda Cole, et al.
Journal of Comparative Effectiveness Research
|
March 1, 2021
Cornerstones of 'fair' drug coverage: appropriate cost sharing and utilization management policies for pharmaceuticals
Steven D Pearson, Adrian Towse, Maria Lowe, et al.
Journal of Comparative Effectiveness Research
|
November 17, 2017
Gene therapy: evidence, value and affordability in the US health care system
Grace Hampson, Adrian Towse, Steven D Pearson, et al.
Journal of Comparative Effectiveness Research
|
November 15, 2018
A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions
Steven D Pearson, William B Dreitlein, Adrian Towse, et al.
Journal of Comparative Effectiveness Research
|
November 10, 2018
Real-world evidence for coverage decisions: opportunities and challenges
Grace Hampson, Adrian Towse, William B Dreitlein, et al.
Health Affairs Scholar
|
June 10, 2024
Towards a coordinated approach for managing accelerated patient access to potentially beneficial medicines: reporting the perspectives of a multi-stakeholder, international workshop
Marie Phillips, Patricia Synnott, Chris Henshall, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?
Chris Henshall, Lloyd Sansom, Hans-Georg Eichler, et al.
Page
of 3